BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 1418692)

  • 1. Adverse drug reactions to systemic antifungals. Prevention and management.
    Perfect JR; Lindsay MH; Drew RH
    Drug Saf; 1992; 7(5):323-63. PubMed ID: 1418692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antifungals for systemic use].
    Ruiz-Camps I; Cuenca-Estrella M
    Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):353-62. PubMed ID: 19482382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic antifungal agents. Drug interactions of clinical significance.
    Albengres E; Le Louët H; Tillement JP
    Drug Saf; 1998 Feb; 18(2):83-97. PubMed ID: 9512916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic optimisation of oral antifungal therapy.
    Schäfer-Korting M
    Clin Pharmacokinet; 1993 Oct; 25(4):329-41. PubMed ID: 8261715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of amphotericin B in the treatment of invasive fungal infections.
    Klepser M
    J Crit Care; 2011 Apr; 26(2):225.e1-10. PubMed ID: 20951541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral antifungal-exacerbated inflammatory flare-up reactions of dermatomycosis : case reports and review of the literature.
    Nikkels AF; Nikkels-Tassoudji N; Piérard GE
    Am J Clin Dermatol; 2006; 7(5):327-31. PubMed ID: 17007544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in topical and systemic antifungals.
    Zhang AY; Camp WL; Elewski BE
    Dermatol Clin; 2007 Apr; 25(2):165-83, vi. PubMed ID: 17430754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungals to treat Candida albicans.
    Moudgal V; Sobel J
    Expert Opin Pharmacother; 2010 Aug; 11(12):2037-48. PubMed ID: 20536294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selecting antifungal agents for the treatment of invasive fungal infections in patients with renal failure.
    Moudgal VV; Sobel JD
    Curr Opin Investig Drugs; 2004 Aug; 5(8):873-8. PubMed ID: 15600244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal drugs.
    Treat Guidel Med Lett; 2005 Feb; 3(30):7-14. PubMed ID: 15671963
    [No Abstract]   [Full Text] [Related]  

  • 11. Antifungal agents and immunomodulators in systemic mycoses.
    Khan ZK; Jain P
    Indian J Chest Dis Allied Sci; 2000; 42(4):345-55. PubMed ID: 15597684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current state of three-dimensional characterisation of antifungal targets and its use for molecular modelling in drug design.
    Ruge E; Korting HC; Borelli C
    Int J Antimicrob Agents; 2005 Dec; 26(6):427-41. PubMed ID: 16289513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications.
    Lyman CA; Walsh TJ
    Drugs; 1992 Jul; 44(1):9-35. PubMed ID: 1379913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview about the medical use of antifungals in Portugal in the last years.
    Manuel da S Azevedo M; Cruz L; Pina-Vaz C; Gonçalves-Rodrigues A
    J Public Health Policy; 2016 May; 37(2):200-15. PubMed ID: 26865319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of systemic fungal infections: alternatives to itraconazole.
    Herbrecht R; Nivoix Y; Fohrer C; Natarajan-Amé S; Letscher-Bru V
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i39-i48. PubMed ID: 16120633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of systemic fungal infections: a pharmacologic perspective.
    Wiebe V; Karriker M
    Clin Tech Small Anim Pract; 2005 Nov; 20(4):250-7. PubMed ID: 16317915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral antifungal agents].
    Tarumoto N; Maesaki S
    Nihon Rinsho; 2008 Dec; 66(12):2373-7. PubMed ID: 19069108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining targets for investigating the pharmacogenomics of adverse drug reactions to antifungal agents.
    Meletiadis J; Chanock S; Walsh TJ
    Pharmacogenomics; 2008 May; 9(5):561-84. PubMed ID: 18466103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal serum concentration monitoring: an update.
    Goodwin ML; Drew RH
    J Antimicrob Chemother; 2008 Jan; 61(1):17-25. PubMed ID: 17999982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of fungal resistance: an overview.
    Balkis MM; Leidich SD; Mukherjee PK; Ghannoum MA
    Drugs; 2002; 62(7):1025-40. PubMed ID: 11985489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.